Phase I/II Study on Concomitant and Adjuvant Temozolomide and Radiotherapy With or Without PTK787/ZK222584 in Newly Diagnosed GBM [glioblastoma multiforme].
Phase of Trial: Phase I/II
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Vatalanib (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Nov 2007 Status change from recruiting to in progress.
- 01 Dec 2005 New trial record.